Harbin Pharmaceutical Group Co., Ltd. provided earnings guidance for the full year 2019. The company predicts a year-on-year decrease of between RMB 270,000,000 and RMB 310,000,000 in its net profit owned by shareholders of the listed company in 2019, a year-on-year decrease of between 78% and 90%. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will decrease by between RMB 255,000,000 and RMB 295,000,000, a year-on-year decrease of between 104% and 121%.